Myriad Genetics Inc.

Myriad Genetics Inc. is a molecular diagnostics and precision medicine company that develops genetic tests to support disease risk assessment, diagnosis, and treatment decisions. The company’s current portfolio spans oncology, women’s health, and pharmacogenomics, with products used for hereditary cancer risk evaluation, tumor profiling, companion diagnostics, reproductive health screening, prenatal testing, and medication-response insights. Its tests are designed for healthcare providers, hospitals, and health systems that use genetic and genomic information to inform patient care across specialties such as cancer, prenatal care, and mental health. Myriad Genetics also offers specialized services that help match patients with targeted therapies and support clinical decision-making through laboratory-based molecular analysis. Headquartered in Salt Lake City, Utah, Myriad Genetics plays an important role in the expanding field of genetic testing, where molecular insights are increasingly integrated into routine medical care.

Sector

Healthcare

Industry

Diagnostics & Research

CEO

Mr. Samraat S. Raha

Employees

2,700

Headquarters

Salt Lake City, UT, United States

Website

www.myriad.com